Procurement Guide for Veterinary POCT¶
This guide helps buyers evaluate veterinary POCT systems — the questions to ask, the total cost to model, and the red flags to avoid.
Evaluation Checklist¶
| Criterion | What to verify |
|---|---|
| Analytical performance | LOD, CV%, correlation — documented |
| Menu breadth | Does it cover your test needs? |
| Throughput | Single vs multi-channel (volume fit) |
| QC system | Daily QC, curve management |
| Documentation | IFU, COA, validation reports |
| Support | Training, service, technical support |
| Regulatory | Market registration status |
Total Cost of Ownership¶
| Cost element | Consideration |
|---|---|
| Instrument | Single-channel cheaper; multi-channel higher throughput |
| Reagents | Per-test cost; volume discounts |
| QC/consumables | Daily QC material |
| Service/maintenance | Warranty, service schedule |
| Training | Initial + ongoing |
Per-test reagent cost often dominates total cost over the instrument lifetime — evaluate the full run-rate, not just hardware price.
Red Flags¶
| Red flag | Why it matters |
|---|---|
| No documented validation | You cannot trust the numbers |
| No COA/IFU | Regulatory/documentation gap |
| No QC system | Results are unverifiable |
| No training/support | Adoption will fail |
FAQ¶
How do I compare two POCT systems? Compare analytical performance (documented), menu breadth, throughput, and total cost of ownership — not just hardware price.
What is the most overlooked cost? Per-test reagent cost and QC consumables over the system lifetime.
For partnership options, see Partnership Models.
Authored by: Migibio Clinical & Scientific Affairs, Guangzhou Magic Biotech Co., Ltd.
Reviewed by: Migibio R&D Quality Committee
Last updated: 2026-08-13
Disclosure: Migibio (Guangzhou Magic Biotech Co., Ltd.) is the manufacturer of the FIA680/FIA880 analyzers and FICT reagents referenced in this content. See our Editorial & Review Policy.